Mesenchymal Stem Cells in Cell Therapy, Regenerative Medicine, and Tissue Engineering

Dear Colleagues,

Mesenchymal stem cells (MSCs) have emerged as a key driver in modern therapy due to their remarkable self-renewal capacity, multilineage differentiation potential, and potent immunomodulatory properties. With advancements being made in the field, the synergy between MSCs and tissue engineering is opening new frontiers for treating previously incurable diseases and injuries.

This Special Issue, "Mesenchymal Stem Cells in Cell Therapy, Regenerative Medicine, and Tissue Engineering", aims to provide a comprehensive platform for the latest breakthroughs in MSC research. We seek original research articles and comprehensive reviews that explore the multifaceted roles of MSCs from fundamental molecular mechanisms and secretome analysis to advanced bioengineering approaches involving innovative scaffolds and 3D bioprinting.

Furthermore, we welcome contributions focusing on the clinical translation of MSC-based products and their application in cell therapy across various medical fields. By bridging the gap between basic laboratory findings and therapeutic applications, this Special Issue seeks to highlight current challenges and future perspectives of MSCs in restoring physiological functions and regenerating damaged tissues. We look forward to receiving your contributions to this exciting and rapidly advancing field. Manuscripts providing original research data are particularly welcome.

Dr. Marta Kot
Prof. Dr. Joni H. Ylostalo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.